# Cogito: A Turnkey Solution for Rapidly Developing, Evaluating, Deploying, and Scaling Digital Therapeutics

> **NCT07104396** · — · RECRUITING · sponsor: **Square2 Systems, Inc.** · enrollment: 20 (estimated)

## Conditions studied

- Substance Use Disorders (SUDs)

## Interventions

- **OTHER:** Cogito digital therapeutics development platform

## Key facts

- **NCT ID:** NCT07104396
- **Lead sponsor:** Square2 Systems, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-02
- **Primary completion:** 2025-08-31
- **Final completion:** 2025-08-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-08-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07104396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07104396, "Cogito: A Turnkey Solution for Rapidly Developing, Evaluating, Deploying, and Scaling Digital Therapeutics". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07104396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*